Press release
Non-invasive Prenatal Testing Market Study Explores Industry Growth Toward $12.37 Billion
Non-invasive Prenatal Testing Market
Market Size Outlook and Growth Drivers for the Non-invasive Prenatal Testing Market
The non-invasive prenatal testing market is expected to expand rapidly, reaching a valuation of $12.37 billion by 2030. This growth corresponds to a strong compound annual growth rate (CAGR) of 14.4%. The surge is primarily fueled by the global rise in uptake of non-invasive prenatal testing methods, increased investments in cutting-edge sequencing technologies, and the broadening infrastructure of hospitals and diagnostic laboratories. Additionally, there is a growing demand for early genetic screening, alongside the progressive integration of artificial intelligence and data analytics within prenatal diagnostics. Key industry trends over the forecast period include wider adoption of AI-driven genetic analysis, expanded use of next-generation sequencing (NGS) and polymerase chain reaction (PCR) systems, implementation of cloud-based data management platforms, greater deployment of high-throughput screening technologies, and advancements in personalized prenatal risk assessments.
The non-invasive prenatal testing market size has grown rapidly in recent years. It will grow from $6.27 billion in 2025 to $7.21 billion in 2026 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to growing awareness of prenatal screening, reliance on invasive diagnostic methods, increasing use of assay kits and reagents, adoption of next-generation sequencing in labs, demand for early detection of chromosomal abnormalities.
Download a free sample of the non-invasive prenatal testing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2492&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Prominent Players Steering the Non-invasive Prenatal Testing Market
Several established corporations currently dominate the NIPT market landscape. These include F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., PerkinElmer Inc., Quest Diagnostics Inc., Agilent Technologies Inc., BGI Diagnosis Co Ltd., Berry Genomics Co, LifeCodexx AG, Myriad Genetics Inc., NIPD Genetics Co Ltd., Sequenom Inc., Annoroad Gene Technology Co Ltd., Centogene AG, Counsyl Inc., EUROFINS Genoma Group, Eurofins Scientific SE, Next Biosciences, Premaitha Health Plc, Ariosa Diagnostics Inc., Yourgene Health PLC, GE Healthcare Technologies Inc., Koninklijke Philips NV, Thermo Fisher Scientific Inc., Pacific Biosciences of California Inc., QIAGEN NV, MedGenome Labs Ltd., Progenity Inc., and Beijing Genomics Institute.
In a notable transaction in January 2024, Natera, Inc., a US-based clinical genetic testing company, acquired reproductive health assets from Invitae for $42.5 million. This acquisition is intended to enhance Natera's portfolio in non-invasive prenatal and carrier screening, crucial areas within reproductive health. Invitae, also a US biotechnology firm, specializes in providing non-invasive prenatal testing services, making this deal strategic for expanding Natera's market presence.
View the full non-invasive prenatal testing market report:
https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Emerging Technologies and Innovations Shaping the Non-invasive Prenatal Testing Market
Industry leaders are focusing on next-generation solutions like linked-SNP (single nucleotide polymorphism) technology to boost diagnostic accuracy, improve the detection of intricate genetic disorders, and reduce dependence on paternal DNA samples. Linked-SNP technology works by analyzing genetically linked markers throughout the genome to infer inheritance patterns, enabling more precise identification of complex mutations such as homozygous variants.
A prime example of this innovation occurred in August 2025, when Natera launched Fetal Focus, a NIPT designed specifically to detect inherited single-gene disorders by analyzing only maternal blood-useful when the biological father is unavailable. This test targets five genes: CFTR, SMN1, HBA1/HBA2, and HBB, and is supported by data from the EXPAND clinical trial. In the initial study involving 101 participants, Fetal Focus demonstrated 91% sensitivity and accurately identified all five fetuses with homozygous variants. This highlights the effectiveness of linked-SNP approaches for non-invasive, reliable prenatal risk evaluation.
Detailed Segmentation of the Global Non-invasive Prenatal Testing Market
The report categorizes the non-invasive prenatal testing market based on several factors:
By Type: Consumables and Instruments
By Application: Trisomy, Microdeletion, Genetics, Rh factor
By End User: Hospitals and Diagnostic Laboratories
Further breakdowns include:
Consumables such as assay kits, reagents, and disposables
Instruments like next-generation sequencers (NGS), polymerase chain reaction (PCR) systems, and ultrasound devices
This comprehensive segmentation helps clarify the market landscape, highlighting the diverse product offerings and application areas driving growth in non-invasive prenatal testing worldwide.
New additions to our 2026 reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-invasive Prenatal Testing Market Study Explores Industry Growth Toward $12.37 Billion here
News-ID: 4611721 • Views: …
More Releases from The Business Research Company
Nucleic Acid Labeling Market Trends Support A 9.9% CAGR Outlook Through The Fore …
The nucleic acid labeling market is on the cusp of significant growth, driven by rapid technological advances and expanding applications in research and diagnostics. As the demand for precise molecular analysis grows, this sector is expected to evolve markedly over the coming years. Below is an overview of the market's size, prominent players, emerging trends, and segment details.
Projected Expansion of the Nucleic Acid Labeling Market by 2030
The global…
Nuclear Medicine Market Report Examines Industry Trends, Growth Drivers And Futu …
The nuclear medicine sector is set to experience significant expansion in the coming years, driven by advancements in technology and growing healthcare needs worldwide. This overview explores the market's anticipated growth, leading companies, emerging trends, and key segments, providing a comprehensive understanding of where the industry is headed by 2030.
Projected Market Value and Growth Trajectory of the Nuclear Medicine Market
The nuclear medicine market is forecasted to expand swiftly,…
Nontuberculous Mycobacterial Infection Market Report Examines Leading Companies …
The market for nontuberculous mycobacterial (NTM) infections is on track for significant expansion in the coming years, driven by advances in treatment options and diagnostic technologies. As healthcare continues to evolve with personalized therapies and AI-powered tools, this sector is receiving increased attention from pharmaceutical companies and medical institutions alike. Below is an overview of the market's projected growth, major players, emerging trends, and segment details that shape the future…
Non-Radiographic Axial Spondyloarthritis Therapeutic Market Outlook Highlights S …
Exploring the growth and innovation in treatments for non-radiographic axial spondyloarthritis reveals a dynamic pharmaceutical landscape. As new therapies emerge and patient care becomes more personalized, the market for these therapeutics is set to expand significantly by 2030. Let's delve into the current market size, the companies leading this space, the important trends driving change, and the key segments that define the industry.
Projected Market Growth of the Non-Radiographic Axial Spondyloarthritis…
More Releases for Prenatal
Non-Invasive Prenatal Testing (NIPT) Market Set to Transform Prenatal Care World …
Market Overview
The global non-invasive prenatal testing NIPT market reached US$ 6.31 billion in 2023 and increased to US$ 7.35 billion in 2024. It is projected to reach US$ 22.41 billion by 2033, growing at a compound annual growth rate CAGR of 13.2% during the forecast period 2025-2033. The market is driven by the rising prevalence of chromosomal abnormalities, increasing maternal age, and growing demand for safe, non-invasive screening methods. NIPT…
Unlocking the Future of Prenatal Care: Insights into the Australia Non-Invasive …
Australia's NIPT market is growing as more parents choose safe, early screening for chromosomal abnormalities. Driven by rising maternal age, advanced sequencing technology, and increasing awareness, NIPT offers high accuracy without invasive procedures. As labs expand test panels and policymakers consider broader reimbursement, NIPT is reshaping prenatal care, making comprehensive and reliable insights accessible to expecting families across Australia.
The Australian non-invasive prenatal testing (NIPT) market is undergoing remarkable growth, transforming…
Revolutionizing Prenatal Care: Insights into the Growing Non-Invasive Prenatal T …
Mordor Intelligence has published a new report on the Non-invasive Prenatal Testing Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
The global non-invasive prenatal testing (NIPT) market is projected to expand significantly, with expectations to grow from USD 3.90 billion in 2025 to USD 7.35 billion by 2030, reflecting a compound annual growth rate (CAGR) of 13.5%. This growth is primarily attributed to…
Prenatal Diagnostics Market Companies Overview 2019 - 2027
Global Prenatal Diagnostics Market: Overview
Prenatal diagnostics is a procedure for testing the fetus before birth to determine certain hereditary disorders such as Down's syndrome, genetic diseases, chromosome abnormalities, neural tube defects, and other conditions. In case of high risk related to the birth of a child, it can assist by conducting numerous procedures of genetic testing common testing, and screening.
Report Overview @ https://www.transparencymarketresearch.com/prenatal-diagnostics-market.html
The global prenatal diagnostics market is segmented on…
Non-Invasive Prenatal Testing Market : Lucrative Opportunities
Non-Invasive Prenatal Testing Market: Introduction
Transparency Market Research has published a new report titled 'Global Non-Invasive Prenatal Testing Market'. According to the report, the global non-invasive prenatal testing market was valued at approximately US$ 1.3 Bn in 2018. The global non-invasive prenatal testing market is expected to expand at a CAGR of 16.4% during the forecast period from 2019 to 2027.
Overview
Rise in prevalence of chronic conditions, such as cancer and diabetes,…
Prenatal Vitamin Supplements Market: Rising Incidence of Prenatal Defects to Fue …
Global Prenatal Vitamin Supplements Market: Overview
Prenatal vitamins are the mineral and vitamin supplements used by during their pregnancy for the healthy development of the fetus. Prenatal vitamins are also recommended by doctors before conception and post conception lactation period. These vitamins are like other common man multivitamins but with different concentration of vitamins and some special vitamins required during pregnancy. Most of these vitamins are prescribed as regulated by U.S.…
